391 related articles for article (PubMed ID: 32505076)
1. Covid-19 and lung cancer: A greater fatality rate?
Rogado J; Pangua C; Serrano-Montero G; Obispo B; Marino AM; Pérez-Pérez M; López-Alfonso A; Gullón P; Lara MÁ
Lung Cancer; 2020 Aug; 146():19-22. PubMed ID: 32505076
[TBL] [Abstract][Full Text] [Related]
2. Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid.
Rogado J; Obispo B; Pangua C; Serrano-Montero G; Martín Marino A; Pérez-Pérez M; López-Alfonso A; Gullón P; Lara MÁ
Clin Transl Oncol; 2020 Dec; 22(12):2364-2368. PubMed ID: 32449128
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
[TBL] [Abstract][Full Text] [Related]
4. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
Rosenberg ES; Dufort EM; Udo T; Wilberschied LA; Kumar J; Tesoriero J; Weinberg P; Kirkwood J; Muse A; DeHovitz J; Blog DS; Hutton B; Holtgrave DR; Zucker HA
JAMA; 2020 Jun; 323(24):2493-2502. PubMed ID: 32392282
[TBL] [Abstract][Full Text] [Related]
5. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
[TBL] [Abstract][Full Text] [Related]
6. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
Million M; Lagier JC; Gautret P; Colson P; Fournier PE; Amrane S; Hocquart M; Mailhe M; Esteves-Vieira V; Doudier B; Aubry C; Correard F; Giraud-Gatineau A; Roussel Y; Berenger C; Cassir N; Seng P; Zandotti C; Dhiver C; Ravaux I; Tomei C; Eldin C; Tissot-Dupont H; Honoré S; Stein A; Jacquier A; Deharo JC; Chabrière E; Levasseur A; Fenollar F; Rolain JM; Obadia Y; Brouqui P; Drancourt M; La Scola B; Parola P; Raoult D
Travel Med Infect Dis; 2020; 35():101738. PubMed ID: 32387409
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
Ip A; Berry DA; Hansen E; Goy AH; Pecora AL; Sinclaire BA; Bednarz U; Marafelias M; Berry SM; Berry NS; Mathura S; Sawczuk IS; Biran N; Go RC; Sperber S; Piwoz JA; Balani B; Cicogna C; Sebti R; Zuckerman J; Rose KM; Tank L; Jacobs LG; Korcak J; Timmapuri SL; Underwood JP; Sugalski G; Barsky C; Varga DW; Asif A; Landolfi JC; Goldberg SL
PLoS One; 2020; 15(8):e0237693. PubMed ID: 32790733
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
[TBL] [Abstract][Full Text] [Related]
10. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Kuderer NM; Choueiri TK; Shah DP; Shyr Y; Rubinstein SM; Rivera DR; Shete S; Hsu CY; Desai A; de Lima Lopes G; Grivas P; Painter CA; Peters S; Thompson MA; Bakouny Z; Batist G; Bekaii-Saab T; Bilen MA; Bouganim N; Larroya MB; Castellano D; Del Prete SA; Doroshow DB; Egan PC; Elkrief A; Farmakiotis D; Flora D; Galsky MD; Glover MJ; Griffiths EA; Gulati AP; Gupta S; Hafez N; Halfdanarson TR; Hawley JE; Hsu E; Kasi A; Khaki AR; Lemmon CA; Lewis C; Logan B; Masters T; McKay RR; Mesa RA; Morgans AK; Mulcahy MF; Panagiotou OA; Peddi P; Pennell NA; Reynolds K; Rosen LR; Rosovsky R; Salazar M; Schmidt A; Shah SA; Shaya JA; Steinharter J; Stockerl-Goldstein KE; Subbiah S; Vinh DC; Wehbe FH; Weissmann LB; Wu JT; Wulff-Burchfield E; Xie Z; Yeh A; Yu PP; Zhou AY; Zubiri L; Mishra S; Lyman GH; Rini BI; Warner JL;
Lancet; 2020 Jun; 395(10241):1907-1918. PubMed ID: 32473681
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Stroppa EM; Toscani I; Citterio C; Anselmi E; Zaffignani E; Codeluppi M; Cavanna L
Future Oncol; 2020 Jul; 16(20):1425-1432. PubMed ID: 32403946
[No Abstract] [Full Text] [Related]
14. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
15. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
Davido B; Boussaid G; Vaugier I; Lansaman T; Bouchand F; Lawrence C; Alvarez JC; Moine P; Perronne V; Barbot F; Saleh-Mghir A; Perronne C; Annane D; De Truchis P;
Int J Antimicrob Agents; 2020 Oct; 56(4):106129. PubMed ID: 32755653
[TBL] [Abstract][Full Text] [Related]
16. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.
Rossi D
Lung Cancer; 2020 Jul; 145():83-84. PubMed ID: 32416433
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study.
Jiménez E; Fontán-Vela M; Valencia J; Fernandez-Jimenez I; Álvaro-Alonso EA; Izquierdo-García E; Lazaro Cebas A; Gallego Ruiz-Elvira E; Troya J; Tebar-Martinez AJ; Garcia-Marina B; Peña-Lillo G; Abad-Motos A; Macaya L; Ryan P; Pérez-Butragueño M; ;
BMJ Open; 2020 Nov; 10(11):e042398. PubMed ID: 33172949
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.
Goicoechea M; Sánchez Cámara LA; Macías N; Muñoz de Morales A; Rojas ÁG; Bascuñana A; Arroyo D; Vega A; Abad S; Verde E; García Prieto AM; Verdalles Ú; Barbieri D; Delgado AF; Carbayo J; Mijaylova A; Acosta A; Melero R; Tejedor A; Benitez PR; Pérez de José A; Rodriguez Ferrero ML; Anaya F; Rengel M; Barraca D; Luño J; Aragoncillo I
Kidney Int; 2020 Jul; 98(1):27-34. PubMed ID: 32437770
[TBL] [Abstract][Full Text] [Related]
19. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
